GLPwatch
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
NCT01988545 · Unknown status
Last updated 2026-05-28This clinical trial tested how a GLP-1 medication affects blood flow in the heart and intestines of healthy adults.
Status Unknown status The sponsor has not confirmed the status recently.
Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).
Type Interventional (clinical trial)
Design Randomized, double-blind basic-science study
Participants 8 people Planned (estimated).
Who can join Ages 20–80 · all sexes Healthy volunteers accepted.
Timeline Started 2013-11 · est. completion 2014-12
Where 1 site · Denmark
What this study is testing ClinicalTrials.gov NCT01988545 ↗
Description as written by the study sponsor.
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters
Treatments tested
- 1,5 nmol/kg,GLP-1 sc injection also known as native GLP-1 Other
- 1,5 nmol/kg GLP-1 9-36amide, sc injection Other
- Exendin-4 ;10 ug,sc injection Other
- saline Other
| Main thing measured | blood flow |
|---|---|
| Sponsor | Zealand University Hospital |
| Conditions studied | Healthy |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01988545 ↗